Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05619913
Title EPOCH: Eribulin and Pembrolizumab in Ovarian/Uterine Carcinosarcoma (EPOCH)
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Australia New Zealand Gynaecological Oncology Group
Indications
Therapies
Age Groups: senior | adult
Covered Countries GBR | CAN | AUS


No variant requirements are available.